Gilead Sciences — Foster City, CA

Why it matters

The pharmaceuticals context.

Post-pandemic supply-chain pressure and bipartisan concern about US reliance on overseas active-pharmaceutical-ingredient (API) production drove an unprecedented wave of domestic pharmaceutical capacity announcements beginning in 2023. Eli Lilly, Novo Nordisk, and Johnson & Johnson lead capacity commitments that exceed any peer's investment in the prior two decades, much of it tied to GLP-1, oncology, and biologics demand.

Project record

At a glance

Company: Gilead Sciences
Industry: Pharmaceuticals
Location: Foster City, California
Investment: $847.0M
Expected jobs: 450
Status: Under Construction
Announced: Apr 25, 2024
Expected opening: Jan 1, 2027
Added to tracker: Feb 18, 2026

Sources

Official references

Primary source
https://www.gilead.com/news

Other projects to know

In California

Advanced Manufacturing
Atomic Machines
Santa Clara, California$156.0M305 jobs
Pharmaceuticals
Amgen (Science Innovation Center)
Thousand Oaks, California$600.0M300 jobs
Semiconductors
Applied Materials (EPIC Center)
Sunnyvale, California$4.00B2,000 jobs
Aerospace
Northrop Grumman (B-21 Production)
Palmdale, California$1.50B2,000 jobs

Across Pharmaceuticals

Pharmaceuticals
Eli Lilly
Goochland County, Virginia$5.00B650 jobs
Pharmaceuticals
Eli Lilly
Huntsville, Alabama$6.00B450 jobs
Pharmaceuticals
Novartis
East Hanover, New Jersey$1.10B1,000 jobs
Pharmaceuticals
Johnson & Johnson
Wilson, North Carolina$2.00B500 jobs

Back to the tracker/projects/gilead-sciences-foster-city